Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Sam Altman, best known as the CEO of OpenAI, has steadily built a large and diverse investment portfolio that spans ...

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Puma Biotech (PBYI) could be a great choice. It is one of the several stocks that ...

"Under Vision 2030, the Kingdom has emerged as a hub to innovate, invest and build the future breakthroughs that will ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

LLR Partners has made a growth investment in TruTechnologies, a Research Triangle Park, North Carolina-based provider of real ...

Stellenbosch University (SU) has announced the opening of the LaunchLab Centre for Epidemic Response and Innovation (Ceri) ...

The field of TCR-T therapies is becoming increasingly crowded, with multiple biotechnology companies and pharmaceutical giants investing heavily in this area. TScan faces the risk of being ...

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

In summary, although deal volume is down, there are fewer but larger deal sizes. Life sciences companies that can demonstrate ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...